Washington Biotechnology and Biomedical Association
Washington Biotechnology and Biomedical Association
Directors
Accessed December 2007: [1]
- James Bianco, M.D., President & CEO, Cell Therapeutics, Inc.
- Anthony Bonanzino, President and CEO, Hollister-Stier Laboratories LLC
- Bruce L. A. Carter, Ph.D., President and CEO, ZymoGenetics, Inc.
- Thomas Clement, President & CEO, Pathway Medical Technologies, Inc.
- Rob Derry, Investment Advisor, Silicon Valley Bank
- Ed Drosdick, Partner, Moss Adams LLP
- Christopher J. Elias, M.D., MPH, President, PATH - Program for Appropriate Technology in Health
- Donald Elmer, Managing General Partner, Pacific Horizon Ventures
- Beth Etscheid, Ph.D., Director of Licensing, Washington Research Foundation
- Jack Faris, Ph.D., President, Washington Biotechnology & Biomedical Association
- H. Perry Fell, Ph.D., President & CEO, NanoString Technologies
- Alan D. Frazier, Founder and Managing Partner, Frazier Healthcare Ventures
- Alan Fuhrman, Senior Vice President & CFO, Sonus Pharmaceuticals, Inc.
- Linda Gainer, Vice President, External Relations and Communications, Fred Hutchinson Cancer Research Center
- Brett V. Gaspers, Managing Director, Objective Insights
- Mitchell H. Gold, CEO, Dendreon Corporation
- James Gore, Vice President, Pacific Northwest Research Institute (PNRI)
- Stephen M. Graham, Managing Partner, Orrick, Herrington & Sutcliffe LLP
- Kayreen Handley, Partner, KPMG LLP
- Douglas R. Hansmann, General Manager, EKOS Corporation
- John F. Harris, President & CEO, NeuroVista Corporation
- Karen Hedine, President & CEO, Micronics, Inc.
- James B. Hendricks, PhD, President, Seattle Children's Hospital Research Institute
- John Hinson, President & CEO, Cardiac Science Corporation
- John Gardner, Vice President for Economic Development and Extension, WSU
- Allan Jones, Ph.D., Chief Scientific Officer, Allen Institute for Brain Science
- Jim Karkanias, Senior Director of Applied Research and Technology, Health Solutions Group, Microsoft
- Kevin F. Kelly, Shareholder, Heller Ehrman Attorneys
- Deborah Kessler, Chief Operating Officer, Acucela
- Bill Kimmerly, PhD, Director, Facilities for Systems Biology & Applications, Pacific Northwest National Laboratory
- Rick Klausner, Partner, The Column Group
- Deborah Knutson, President, EDC of Snohomish County
- Michael Kranda, Director of Biotechnology Venture Investments, Vulcan Inc.
- Thong W. Le, Managing Director, WRF Capital
- Bill Lewis, President & CEO, Lease Crutcher Lewis
- Jim Lisbakken, Partner & Chair of Life Sciences Practice Group, Perkins Coie LLP
- Carl Mackleit, Senior Tax Manager, Ernst & Young LLP
- Tim Martin, Director of State Government Relations, Amgen
- Margaret McCormick, Ph.D., Partner, Integra Ventures
- A. Bruce Montgomery, M.D., Senior VP, Gilead Respiratory Therapeutics
- Jack Nagan, Executive Director Benaroya Research Institute at Virginia Mason and VP Research, Virginia Mason Medical Center
- H. Stewart Parker, President & CEO, Targeted Genetics Corporation
- Jens Quistgaard, President & CEO, Liposonix, Inc.
- Erick Rabins, Vice President, Allied Minds, Inc.
- J. Thomas Ranken, Co-Founder and CEO, VizX Labs, LLC
- Gregory Sessler, Chief Financial Officer, Spiration, Inc.
- James A. Severson, Ph.D., Vice Provost, Intellectual Property & Technology Transfer, UW TechTransfer
- Clay B. Siegall, Ph.D., President & CEO, Seattle Genetics, Inc.
- John Steel, Partner, DLA Piper US LLP
- Terry Sweeney, Senior Vice President Quality & Regulatory Affairs, Philips Ultrasound
- Peter Thompson, M.D., President & CEO, Director, Trubion Pharmaceuticals, Inc.
- Carl Weissman, President & CEO, Accelerator Corporation
- Michael Wiley, MBA Biotech Club, University of Washington
- Susan Wray Spraitzar, DDS, JD, Senior Director of Regulatory & Intellectual Property, Light Sciences Oncology, Inc.
Contact
- Web: http://www.wabio.com